论文部分内容阅读
采用国产ｒＩＬ－２诱导人同种异体胎脾、胎胸腺ＬＡＫ细胞治疗２２例晚期恶性肿瘤患者。结果表明，全部病人症状和体征均有不同程度改善；Ｋａｒｎｏｆｓｋｙ评分平均提高１３．６分；２２例患者中ＣＲ２例，ＰＲ７例，有效率４０．９１％。提示以胎脾、胎胸腺作为ＬＡＫ前体细胞具有一定的临床价值。
The use of domestic rIL-2 induced human allogeneic spleen, fetal thymus LAK cells in the treatment of 22 patients with advanced malignant tumors. The results showed that the symptoms and signs of all patients improved to varying degrees; the Karnofsky score increased by an average of 13.6 points; in 22 patients, there were 2 CRs and 7 PRs with an effective rate of 40.91%. Tips to spleen, fetal thymus gland as LAK precursor cells have a certain clinical value.